Discover why Recursion Pharmaceuticals, Inc. stands out in AI drug discovery, but faces valuation risks. Click for my look at ...

PageRank interpreted hyperlinks as endorsements, prioritizing pages linked by many others and weighting endorsements from ...

Power first, models second AI is no longer constrained primarily by algorithms or capital; it is constrained by electrons.

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

15-451/651 is an advanced undergraduate/masters algorithms class. We cover fundamental algorithmic modeling techniques (e.g. dynamic programming, graphs, network flows, linear programming), advanced ...

By David Swanson, World BEYOND War Ah, those were the days. The UN had been blocked by a worldwide popular movement from ...

You can create a release to package software, along with release notes and links to binary files, for other people to use. Learn more about releases in our docs.

In a Q&A, Recursion’s incoming CEO acknowledges hype around the idea of using AI to expedite drug development, and says it's ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week.

This week, my colleagues and I scheduled 30 minutes to talk with Mark Cuban for “The Readout LOUD” podcast. The conversation ...